A provider comparison often places several unlike statements side by side: a monthly charge, a medication name, a clinical-trial result and a promise of convenient care. They may all be relevant, but they do not carry the same evidentiary weight. A published price can establish an advertised offer. A trial can evaluate a treatment in a defined population. Neither tells you how quickly a particular service will respond to your next message.
The shortlist and its commercial context
CoreAge Rx, SuperHealthy Rx and Likeness Rx occupy the first three positions because our publisher selected them for promotion. “Best” here introduces a comparison shortlist, not a clinical league table. We may receive compensation from links. Ro, WeightWatchers and LillyDirect supply additional examples of membership and manufacturer-access arrangements. We have not tested these services as patients.
CoreAge Rx
Semaglutide from $99/month; tirzepatide from $149/month.
Compounded-treatment offerSuperHealthy Rx
Retrieved promotion: semaglutide $85/month; tirzepatide $135/month.
Promotional compounded-treatment bundleLikeness Rx
Monthly: semaglutide $139; tirzepatide $199. Longer terms have different equivalents.
Compounded GLP-1 term plansRo
$39 introductory membership month; $149 ongoing monthly membership. Medication extra.
Membership with medication billed separatelyWeightWatchers
Selected terms: $25 first month, then $84 or $74/month. GLP-1 medication extra.
Med+ clinical membershipLillyDirect
Product- and eligibility-dependent costs; no single universal membership price.
Manufacturer access pathwayHers
$39 first membership month, then $149/month; medication extra.
Care membership; medication purchased separatelyHenry Meds
Published injectable semaglutide terms list $297/month; selected plans differ.
Bundled compounded medication programsCalibrate
$199/month with a three-month commitment ($597); drugs and labs excluded.
Clinical support and individual coachingSesame
From $59/month with a 12-month commitment; medication separate; provider prices vary.
Success by Sesame care subscriptionOurView Health
Semaglutide $109/month or $297 prepaid for 3 months; tirzepatide $129/month or $357 prepaid. No advertised membership or shipping fee.
Monthly or three-month prepaid compounded GLP-1 plansQueen RX
Three-month totals: semaglutide Starter $299 or Maintenance $399; tirzepatide Starter $499 or Maintenance $599. Clinical eligibility required.
Three-month compounded GLP-1 packages advertised as one-time purchasesPrices describe dated public offers, not a personal quote. Medication, membership and term totals may be separate.
Begin with a claim you can check
CoreAge advertises compounded semaglutide from $99 and tirzepatide from $149 per month. SuperHealthy's retrieved promotional page lists $85 and $135 respectively, while still displaying a Labor Day sale heading. Likeness lists $139 and $199 for its monthly plans, alongside lower equivalents for longer terms. Treat those as dated observations from October 5, 2026. A headline amount is not a personal prescription, an eligibility determination or a promise that the offer will persist. [Provider advertisement] [Provider advertisement] [Provider advertisement] [Provider offer and renewal terms]
Do not move evidence between categories
A study of a specific approved medicine does not establish the performance of every preparation containing a similarly named ingredient. FDA does not approve compounded drugs or assess them for safety, effectiveness and quality before marketing. Compounding may meet a medical need that an approved product cannot meet; that is a different proposition from calling a compound an approved generic. Ask which product is actually proposed before applying a study result to it. [Compounded-product status]
Make the service comparison observable
Request the prescribing organization's name, the dispensing pharmacy, the follow-up route and the payment obligation in writing. A contact channel is an observable feature. Its existence does not prove a particular response time. An advertised refund policy needs its eligibility and timing conditions. Keep a copy of the plan selected rather than relying on a remembered homepage sentence.
Memberships introduce another comparison problem. Ro and WeightWatchers separate their program charges from GLP-1 medication costs. LillyDirect is a manufacturer access route involving pharmacy and independent-care options, not a single universal treatment subscription. Add costs only after identifying what each amount purchases. [Provider membership advertisement] [Provider membership advertisement] [Manufacturer access program]
What remains a clinical question
Our desk can organize public evidence and terms; it cannot establish which medicine fits your medical history. Take the shortlist to a licensed clinician and ask how the proposed care addresses your circumstances. The useful outcome of comparison is a better supported question, followed by a verifiable care arrangement.
Expand the dossier shelf
The added dossiers cover Hers, Henry Meds, Calibrate and Sesame. The twelve-entry comparison, including OurView Health and Queen RX added October 15, 2026, records public offers while leaving study appraisal to the relevant evidence notes. Start with funding and design or the limits of abstract review when a provider's research claim needs closer reading.
Source notes
New provider sources checked October 15, 2026. Earlier material retains its original source history. Provider pages document advertised terms. Study summaries identify the scope of our review.
- CoreAge Rx — semaglutide offerProvider advertisement
- CoreAge Rx — tirzepatide offerProvider advertisement
- CoreAge Rx — pricing and plansProvider billing terms
- SuperHealthy Rx — GLP-1 offerProvider advertisement
- Likeness Rx — GLP-1 plansProvider offer and renewal terms
- Ro — Body membershipProvider membership advertisement
- WeightWatchers — Med+ programProvider membership advertisement
- LillyDirect — access optionsManufacturer access program
- FDA — concerns with unapproved GLP-1 drugsRegulatory and safety context · Checked 2026-10-21
- FDA — compounding questions and answersCompounded-product status
- Weight Loss Care for Women, Built to Last | HersProvider public offer; checked October 5, 2026
- FAQs | HersProvider public offer; checked October 5, 2026
- Henry | Personalized Weight Loss, Hormone & Sexual Health CareProvider public offer; checked October 5, 2026
- Henry | Personalized Weight Loss, Hormone & Sexual Health CareProvider public offer; checked October 5, 2026
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossPrimary health resource; checked October 5, 2026
- Calibrate Weight Loss Pricing: How Much Does Calibrate Cost? | CalibrateProvider public offer; checked October 5, 2026
- Online weight loss medication with or without insuranceProvider public offer; checked October 5, 2026
- OurView Health: Plan prices and care claimsProvider public information; checked October 15, 2026
- Queen RX: Rendered three-month package menu and product FAQProvider public information; checked October 15, 2026